Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) vs Viavi Solutions Inc. Common Stock — how do they compare? Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.69 (market cap $58.74B), while Viavi Solutions Inc. Common Stock trades at $45.66 (market cap $10.85B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 5.4× Viavi Solutions Inc. Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while Viavi Solutions Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days and Viavi Solutions Inc. Common Stock for 0 Days on average.
| TAK | VIAV | |
|---|---|---|
Market Cap | $58.74B | $10.85B |
Volume | 3,110,994 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $19.05 | $55.33 |
52-Week Low | $13.23 | $12.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $86.65B | $10.89B |
Dividend Yield | 3.33% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →